📌 In AF 👫 w/ high🩸bleeding risk (BR) & relatively low🧠stroke risk (SR) 👉 low-dose DOAC regimen ⬆️ SR without ⬇️ BR #afib #stroke #CardioTwitter Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 Diego Segura-Rodríguez Prof Dhiraj Gupta Thomas Jared Bunch Jag Singh Jason Andrade Dr Anastasia Mihailidou FAHA FCSANZ FESC Dominik Linz Andrea Natale MD

We followed >8000 Danes with atrial fibrillation who had a stroke and started/restarted DOAC. For incidence rates of stroke recurrence, association of recurrence with DOAC discontinuation & more, see our article in #JAMA Neurology: jamanetwork.com/journals/jaman…

Parlons des #AVC hémorragiques et de notre nouveau programme de recherche TIPITCH vendredi 28/6 à 16h - Lille Salle des congrès, fac médecine pôle Recherche CHU de Lille UFR des Sciences de Santé et du Sport (UFR3S) Université de Lille Inserm Nord Ouest Ensemble, prenons soin de nos 🧠

Danish observational study found recurrent ischemic stroke while on DOACs is common with a 1-year risk of 4% for patients with atrial fibrillation. Prior stroke is a risk factor. DOAC discontinuation doubles the risk of ischemic stroke. ja.ma/3VEBCFT OUH Odense Svendborg Aarhus Uni.hospital

👏👏 important new data from David Gaist and team! high residual risk in patients with AF and recent stroke valeria caso . Particularly in patients with #breakthroughstroke despite OAC! Add-on #LAAO the Future? Lorenz Räber, MD PhD Urs Martin Fischer ELAPSE Stroke Research Center Bern Thomas Meinel

#CVCT2024 : NEUROCARDIOLOGY: RUNNING MULTIDISCIPLINARY TRIALS IN AN EMERGING SPECIALTY, with Edip Gurol, SCAN Lab (Rebecca Gottesman), Seemant Chaturvedi and many others ! Discover the full programme here : globalcvctforum.com/scientific-pro… #CVCT #Cardiology #clinicaltrials #clinicalresearch

📌 Device-detected AF 👉 Pro & Contra of Anticoagulation #afib #CardioTwitter #stroke #ECG Prash Sanders Mintu Turakhia, MD MS Diego Segura-Rodríguez Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 JK Han MD Thomas Jared Bunch Jonathan Piccini, MD, MHS Rod Passman Dr Anastasia Mihailidou FAHA FCSANZ FESC Jag Singh Prof Dhiraj Gupta ecgrhythms Hany Ragy Shelley Zieroth

📌 Best antithrombotic therapy after LAA occlusion 👉 Low-Dose NOAC or DAPT❓ #afib #CardioTwitter #EPeeps Diego Segura-Rodríguez Thomas Jared Bunch Jonathan Piccini, MD, MHS Jason Andrade Prof Dhiraj Gupta Amin Al-Ahmad, MD SABOURETCardiologist Kamala Tamirisa MD Edip Gurol Hany Ragy Mamas A. Mamas Piotr Futyma, MD Tom De Potter Ritu Thamman MD

📌 In AF 👫 treated w/ apixaban or rivaroxaban who need drugs to control ventricular rate 👉 use of diltiazem instead of metoprolol ⬆️ risk of serious bleeding #afib #CardioTwitter #MedTwitter Jason Andrade Prof Dhiraj Gupta Prash Sanders Dominik Linz Piotr Futyma, MD Tom De Potter Hany Ragy

OAC is powerful to lower the stroke risk in patients with AFib but there is a residual risk for breakthrough strokes. We need to explore new approaches to protect the brain ELAPSE #INTERCEPT Alexander Benz PHRI.ca Population Health Research Institute 🇨🇦 Stroke Research Center Bern Cardiovascular Research Cluster (CVRC) European Stroke Org WorldStrokeAcademy

Virtual Open House 💻 Join us on Thursday Sept 5 from 6-7 PM EST for a virtual open house! Learn more about our program, meet current residents and faculty and ask questions! Register at the link in our bio! 🧠 See you there!

Looking forward to revealing the results of the STEEER-AF cluster randomised clinical trial at the Late Breaking ESC Hotline session during the #ESCCongress 2024 in #London •Speaker: Professor Dipak Kotecha •Date: Sunday, 1st September •Time: 08:15 AM to 09:41 AM UK

#CVCT2024 : The ultimate dive into the latests clinical trials with the largest global gathering of key stakeholders is waiting for you, December 9-11, 2024 in Washington DC ! Discover the program here : globalcvctforum.com/scientific-pro… #clinicaltrials #clinicalresearch #CVCT

Great to catch up Edip Gurol #ESCCongress

New on the The Lancet-JACC Journals collaboration! We detail our joint efforts to accelerate progress in global cardiovascular health. Read about our work towards better heart health for all. American College of Cardiology #ESCCongress authors.elsevier.com/a/1jgxA2d9GH%7…

OCEANIC-AF trial shows factor XI inhibitor asundexian was inferior for preventing stroke and systemic embolism vs. apixaban in pts with Afib and high stroke risk. Trial stopped early due to inferiority of asunxdexian. #ESCCongress

Sleep apnea stands out here in recommendations - I will be discussing the data related to our recommendations at #ESC2024 on 2.9.2024 in session “Weighty Matters” 0815 am in room Cairo Melissa Middeldorp Pier Lambiase Melanie Gunawardene Jose Luis Merino Prof Dhiraj Gupta

Just a lovely time spent with Edip Gurol this evening talking research, medicine, & ‘pot washing’! Thanks!

📌 OCEANIC AF 👉 Asundexian -fact XIa inhibitor- vs apixaban in AF👫 ♦️ less effective to prevent stroke 🧠 ♦️ assoc w/ fewer major bleeding 🩸 #afib #stroke #OAC #CardioTwitter Jonathan Piccini, MD, MHS Andrea Russo Prof Dhiraj Gupta SABOURETCardiologist Diego Segura-Rodríguez rafavidalperez Prof Chris P Gale

A warm Welsh welcome to Cardiff for the 🇹🇷 team for the UEFA Nations League match 🏴󠁧󠁢󠁷󠁬󠁳󠁿 vs 🇹🇷 Croeso i Gymru! Great to be in Cardiff w/ Amb Osman Koray Ertaş & CG Seyfi Onur Sayın. Football ⚽️ is one of the many shared passions between our two countries. May the best team win!